|
Volumn 49, Issue 1, 2001, Pages 11-16
|
The role of neoadjuvant radiochemotherapy using low-dose fraction cisplatin and 5-fluorouracil in patients with carcinoma of the esophagus.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
AGED;
ARTICLE;
CHI SQUARE DISTRIBUTION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESOPHAGUS RESECTION;
ESOPHAGUS TUMOR;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
NONPARAMETRIC TEST;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
SURVIVAL;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CHI-SQUARE DISTRIBUTION;
CISPLATIN;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
STATISTICS, NONPARAMETRIC;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0035221222
PISSN: 13444964
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02913117 Document Type: Article |
Times cited : (7)
|
References (0)
|